跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAG G
首页
药物
TAG G
TAG G
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PNA probes, probe sets, methods and kits pertaining to the detection of Candida
US 8026051 B2
申请人: BOSTON PROBES INC
优先权: 2002
US
7 件公开
Gene knockout method based on base editing and its application
US 11248225 B2
申请人: SUZHOU MAXIMUM BIO TECH CO LTD
优先权: 2017
CN
US
WO
4 件公开
Adapter-based retroviral vector system for the selective transduction of target cells
US 12365916 B2
申请人: MILTENYI BIOTEC BV & CO KG
优先权: 2017
CN
EP
US
4 件公开
Methods and compounds for detecting beta-lactamase activity
US 8802387 B2
申请人: XING BENGANG
优先权: 2008
US
4 件公开
Peptide-based method for monitoring gene expression in a host cell
EP 1580273 A1
申请人: UNIV FRIEDRICH ALEXANDER ER
优先权: 2004
EP
US
2 件公开
Multivalent Chelators for Modifying and Organizing of Target Molecules
US 2008038750 A1
申请人: PIEHLER JACOB
优先权: 2004
US
WO
2 件公开
Soluble expression of protein using peptide tag
US 12398382 B2
申请人: IDEMITSU KOSAN CO
优先权: 2018
CN
US
2 件公开
CD62L specific lentiviral vector particle for targeted transduction of T cell subsets
US 12018273 B2
申请人: MILTENYI BIOTEC BV & CO KG
优先权: 2020
EP
US
2 件公开
PEPTIDE TAG AND NUCLEIC ACID ENCODING SAME
US 20250258180 A1
申请人: STAND THERAPEUTICS CO LTD
优先权: 2021
CN
US
2 件公开
EXPRESSION AND PURIFICATION METHOD FOR RECOMBINANT HUMAN INTERLEUKIN-15
WO 2025066687 A1
申请人: WUXI BIOLOGICS SHANGHAI CO LTD
优先权: 2023
CN
WO
2 件公开
第 1 / 6 页
上一页
下一页
药物
反馈